Not really? A demonstrable mechanism exists by which ArA, and other phospholipid substrates can enhance signaling of myokine pathways.
In fact, I could probably make a feasible marketing case that arachidonic acid should inhibit myostatin, given various logical leaps based on IL-6 and NF-Kb pathway interactions with myostatin.
--
Did you even read my post? I not once said the ingredient didn't work.
I simply said that myostatin inhibition as a primary target/effect is unlikely given the clinical effects of myostatin inhibition on the scale seen in related studies compared to the anecdotal effects in users.
Oh I do. I remember when Bill L got hammered about it. Surprised you don't remember that.
I read your post, and my post was simply a reminder that Bill got hammered over an ingredient in which everyone stated "did not work", was "unhealthy"...all based on "research". In short, things evolved.